Rocket Pharmaceuticals said on Friday the U.S. health regulator declined to approve its gene therapy to treat a rare and severe pediatric disorder that causes the immune system to malfunction, sending its shares down more than 12% in early trading. The Food and Drug…
House Republicans Disavow Project 2025
As House Democrats try to tie Republicans to Project 2025, House Republicans are distancing themselves from Heritage Foundation’s blueprint for a potential second term for